About BioChain
BioChain is a Healthcare company based in Hayward (United States) founded in 1994. BioChain has raised $7.34 million across 2 funding rounds from investors including HHS and Ascendent Capital Partners. Its chief executive, as recorded, is Grace Tian. Its website biochain.com draws about 21 thousand monthly visits. BioChain offers products and services including Biospecimens, Extraction Kits, Automated Instruments, and Custom Services. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is BIOCHAIN INSTITUTE, INC. Its competitors include GenScript, Meridian Bioscience and Teknova; 1 of its 3 listed competitors has raised funding.
Company details
Provider of products and services for clinical diagnosis, genomics, and proteomics. The products (markers, kits, reagents) for DNARNA and proteins related research. It provides kits for sequencing, enzyme assays, PCR, immunodiagnostics. Also offers an extensive collection of tissue blocks, slides, frozen arrays, and FFPE arrays for human normal, diseased, and tumor tissue types. It provides custom services such as clinical samples collection, extraction and purification, tissue section and array, and others.
- Headquarters Hayward, United States
- SectorsHealthcare
- Website biochain.com
- Social LinkedIn X Facebook YouTube
- Legal Name Biochain Institute, Inc.
- Total Equity Funding$7.34M (USD)
in 2 rounds
- Latest Funding Round$7.34M (USD), Private Equity Round
Nov 2016
- InvestorsHHS
& 1 more
Products & Services of BioChain
BioChain offers a comprehensive portfolio of products and services, including Biospecimens, Extraction Kits, Automated Instruments, and Custom Services.
High-quality tissues and samples for research and testing purposes
Kits for DNA, RNA, and protein extraction in laboratories
Devices for automated sample preparation and analysis
Tailored biospecimen procurement and analysis for clients
Apps and channels of BioChain
its YouTube channel BioChain Institute Inc. has 52 subscribers and 13 videos.
Videos from BioChain
The most watched videos on BioChain's YouTube channel, BioChain Institute Inc. (52 subscribers). Click a video to play it here.
More on BioChain Institute Inc..
Funding Insights of BioChain
BioChain has successfully raised a total of $7.34M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $7.34 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.34M
- Total Rounds 2
- Last Round Private Equity Round — $7.34M
- First Round $200,435
(May 2008)
- Investors Count 2
All 2 funding rounds of BioChain with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2016 | $7.34M | Private Equity Round | – | Ascendent Capital Partners | – |
| May 2008 | $200,435 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in BioChain
BioChain has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Ascendent Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ascendentcp.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for BioChain
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioChain
5 people are tracked at BioChain (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Grace Tian | CEO | Leadership |
Vidyodhaya Sundaram, PhD, MBA | Vice President of Business Development | Leadership |
Vanita Jogani | Associate Director Of Channel Sales And Marketing | Leadership |
Gerardo Plascencia | Sales Representative | Team |
Tina Kinoshita | Marketing/Sales Coordinator | Team |
Complete people profiles for BioChain
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioChain
3 dated milestones of BioChain across 22 years, from founding to its latest funding, stage changes and deals.
- Founded BioChain is founded.
- Funding First funding round of $200K.
- Funding Latest funding round, Private Equity Round, of $7.3M.
Competitors of BioChain
BioChain has 3 listed competitors in our database, 1 of them funded. They include GenScript, Meridian Bioscience and Teknova.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits | |||
| teknova.com | 1996 | Hollister, United States | 290 | Molecular biology reagents and kits are supplied for research applications. |
Detailed competitors of BioChain
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioChain
The website of BioChain (biochain.com) receives about 20.6K visits a month.
- Monthly visits20.6K
▲ 2.9% vs previous month
Websites whose visitors overlap most with BioChain. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bio-world.com | bio-world.com | 100% | #901,632 | – | |
| biocat.com | 97% | 37.9K | #866,969 | View details | |
ebiohippo.com | ebiohippo.com | 90% | #1,393,194 | – | |
komabiotech.co.kr | komabiotech.co.kr | 86% | #1,931,229 | – | |
flowgen.net | flowgen.net | 84% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for BioChain
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as BioChain (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biochain
Complete news archive for BioChain
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioChain
BioChain was founded in 1994 and raised its 1st funding round 14 years after it was founded.
BioChain is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Grace Tian is the CEO of BioChain, as recorded in our data.
BioChain is a funded company, having raised a total of $7.34M across 2 funding rounds to date. The company's 1st funding round was a Grant of $200.44K, raised on May 2008.
Provider of products and services for clinical diagnosis, genomics, and proteomics. The products (markers, kits, reagents) for DNARNA and proteins related research. It provides kits for sequencing, enzyme assays, PCR, immunodiagnostics. Also offers an extensive collection of tissue blocks, slides, frozen arrays, and FFPE arrays for human normal, diseased, and tumor tissue types. It provides custom services such as clinical samples collection, extraction and purification, tissue section and array, and others.
BioChain's top competitors include Meridian Bioscience, GenScript and Teknova.
BioChain offers Biospecimens, Extraction Kits, Automated Instruments, and Custom Services.
BioChain has 2 investors. Key investors include HHS, and Ascendent Capital Partners.
BioChain operates through Biochain Institute, Inc..